A clinical evaluation of pyridostigmine bromide in the reversal of pancuronium.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000771:Anesthesia, Intravenous; D000777:Anesthetics; D055598:Chemical Phenomena; D002621:Chemistry; D004558:Electric Stimulation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine; D009407:Nerve Block; D010197:Pancuronium / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D011729:Pyridostigmine Bromide / Q000009:adverse effects / Q000494:pharmacology*; D012018:Reflex; D013390:Succinylcholine; D014459:Ulnar Nerve / Q000502:physiology
D000777:Anesthetics; D009388:Neostigmine; D013390:Succinylcholine; D010197:Pancuronium; D011729:Pyridostigmine Bromide